PolicyBazaar’s parent PB Fintech to form a payment aggregator subsidiary
PolicyBazaar’s promoter PB Fintech on Wednesday said its board has approved the incorporation of a wholly-owned subsidiary for payment aggregator business. The new subsidiary called PB Pay Private Limited would “carry on the business of payment aggregator – domestic and / or cross border or both, as may be permitted by the Reserve Bank of India, by facilitating merchants with offline and/or digital payment acceptance infrastructure or both,” the company said in a regulatory filing. On February 1, Singapore-based sovereign wealth fund Temasek Holdings had sold its entire 5.42 per cent stake in PolicyBazaar's parent firm PB Fintech for ₹2,425 crore through open market transactions. Temasek Holdings’ wholly-owned subsidiary Claymore Investments Pte Ltd sold the shares of PB Fintech in three tranches on the BSE. In January, Japanese conglomerate Softbank's arm Svf Python II divested a 2.5 per cent stake in PB Fintech for ₹914 crore.










SoftBank plans to sell 5% stake in Policybazaar via block deal tomorrow: Report
Discover Related

Stocks to watch: Titan, BEL, M&M, Tata Motors, KPI Energy among shares in focus today

Ranjeet Mechatronics, Capital Trade Links to trade ex-bonus today; Do you own?

Haldiram's to sell stake to Singapore's Temasek, says PwC

Haldiram To Sell 10 Per Cent Stake To Temasek In Deal Valuing Firm At $10 Billion

Goldman Sachs is bullish on HAL, Zomato shares. Do you own?

Goldman Sachs is bullish on HAL, Zomato shares. Do you own?

Hexaware is back on the bourses. What should investors expect?

Blackstone to buy 40 pc stake in Kolte-Patil Developers for over ₹1,150 cr

Tata Capital board okays IPO plan, likely to raise Rs 15,000 crore

Stocks to Watch: Tata Steel, M&M Financial Services, RVNL, HG Infra, and more

ED Freezes ₹170 Crore in Bank Deposits in Forex Scam Probe

Stocks to Watch: RIL, Vodafone Idea, Godrej Industries, Kotak Bank, and more

Three public sector banks may put government stake on sale in FY26

Biocon Biologics sees insulin demand growing across markets, says CEO Tambe

Exclusive: Fiitjee auditor flagged accounts loopholes weeks before centres were shut

FII game plan: Sell stocks for profit, bet on IPOs, discounted QIPs, block deals

Kotak Mahindra Bank acquires Standard Chartered’s ₹3,300 crore personal loan portfoilio
